OSR Health, Inc. (OSRH) Cash & Equivalents (2023 - 2026)

OSR Health has reported Cash & Equivalents for 4 years, with the latest figure at $1.6 million in Q1 2026.

• Quarterly Cash & Equivalents fell 1.82% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 1.82% YoY) and the FY2025 annual result came in at $1.7 million, up 397.82% from the prior year.
• Cash & Equivalents eased to $1.6 million in Q1 2026 per OSRH's latest filing, from $1.7 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $70.6 million in Q1 2023 and troughed at $3637.0 in Q1 2024.
• A 4-year average of $7.2 million and a median of $1.6 million in 2026 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents tumbled 99.99% in 2024, then jumped 43773.99% in 2025.
• Over 4 years, Cash & Equivalents stood at $15419.0 in 2023, then soared by 2115.08% to $341543.0 in 2024, then jumped by 397.82% to $1.7 million in 2025, then declined by 7.86% to $1.6 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $1.6 million, $1.7 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.